There is overwhelming evidence for a significant genetic contribution to the etiology of schizophrenia. Molecular genetic techniques are now sufficiently advanced to be applied to complex genetic disorders with uncertain phenotypes, such as schizophrenia. In this article we first briefly discuss certain pertinent background issues: the evidence that schizophrenia has a heritable basis, the possible modes of inheritance in~rolved, and how best to define schizophrenia in the light of this evidence; we then review the current status of research in the field. Large collaborative studies are currently underway that pave the way for the detection of genes of both major and minor effects. We may now be seeing the first consistently replicated results from chromosome 6 and 22 and from candidate genes, such as the dopamine D3 receptor gene.
Introduction

Genetic Epidemiology
The revolution in molecular biology based on recombinant DNA technology has profoundly altered and enhanced the prospects for molecular genetic research into schizophrenia. In the main part of this article we shall review the current status of research in the field, but first we shall briefly discuss certain pertinent background issues: the evidence that schizophrenia has a heritable basis, the possible modes of inheritance involved, and how best to define schizophrenia in the light of this evidence.
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Murphy, Cardno, and McGuffin standardized research interviews (e.g., Spitzer et al., 1978; Wing et al., 1990 ) the diagnosis of schizophrenia can be made reliably, which is an important prerequisite to achieving a valid definition. Furthermore, as we shall discuss below, the commonly used operational definitions of schizophrenia also have demonstrable heritability.
Most of the evidence that schizophrenia includes an important genetic component comes from family, twin, and adoption studies. Gottesman (1991) pooled the results of European family studies carried out between 1920 and 1987. In general, an individual's lifetime risk of developing schizophrenia increased exponentially the more closely related he or she was to an affected individual (or proband) . Thus, compared with the general population risk of around 1%, the risk to cousins of probands was 2%, the risk to siblings was 9%, and the risk to identical twins was 46%. Also, the risk increased as a function of the number of relatives affected. For example, the risk to someone with an affected sibling and an affected parent was 16%. The majority of studies contributing to this data were performed before the advent of operational definitions, but the results of more recent studies employing such criteria remain consistent with those of the older studies (Kendler et al., 1993a) .
Family studies show clearly that schizophrenia is familial, but do not tell us to what extent this relationship is caused by genetics. The next step to answering this question is twin studies. These compare the concordance for schizophrenia in monozygotic (MZ) twin pairs, who share all of their genes in common, with the concordance in dizygotic (DZ) twin pairs, who share half of their genes, the same proportion as siblings in general. Assuming a similar level of environmental influences on both kinds of twins, if the MZ concordance rate is significantly greater than the DZ rate a genetic influence may be inferred. In addition, the application of such techniques as path analysis (Li, 1976 ) allows estimates to be made of the size of additive genetic effects (heritability) as well as environmental effects. Gottesman and Shields (1982) pooled the results of systematically ascertained European twin studies and found the weighted probandwise concordance rate for MZ twins to be 46% whereas that for DZ twins was 14%, consistent with a genetic contribution. As in the case of family studies, more recent research using operational definitions has produced consistent results. Farmer et al. (1987) , in the United Kingdom, reanalyzed data from Gottesman and Shields' (1972) Maudsley twin series and found the following concordance rates: MZ, 48%; DZ, 9%. Onstad et al. (1991) , using the Norwegian national twin register, found an equivalent MZ rate of 48% and a DZ rate of 4%. McGue et al. (1985) performed path analysis on European family and twin study data and obtained a heritability estimate of 63%. Subsequently, McGuffin et al. (1994) applied path analysis to the combined data of Farmer et al. (1987) and Onstad et al. (1991) . The full model, which includes estimates of additive genetic effects, common environmental, and nonshared environmental effects, resulted in a similar level of heritability. However, McGuffin and colleagues found that the common environmental component could be removed without significantly affecting the model-fit but increasing the heritability estimate to 87.5%.
Critics of twin studies have suggested that the above results could be caused by MZ twins identifying with each other more strongly than DZ twins rather than by genetic effects. However, Gottesman and Shields (1982) examined the small number of MZ twin pairs from systematically ascertained studies who had been brought up apart and found their concordance rate to be slightly higher (58%) than the weighted concordance rate for all MZ pairs (46%).
Twin studies, therefore, provide good evidence of an important genetic contribution to the etiology of schizophrenia. Another means of examining the relative genetic and environmental contributions to schizophrenia is adoption studies. These take a variety of forms, but basically compare the prevalence of schizophrenia in biological relatives who have been separated by adoption early in life and in adoptive relatives who have shared the same environment but who are not genetically related. A higher prevalence of schizophrenia in the biological than the adoptive relatives is consistent with a genetic effect. The first schizophrenia adoption study was performed by Heston (1966) in Oregon. He examined the prevalence of schizophrenia in the adopted offspring of 50 mothers with schizophrenia and compared this with the prevalence in control offspring with unaffected mothers. He found a rate of schizophrenia of 16.6% in the offspring of schizophrenic mothers and no cases of schizophrenia in the control offspring (p = 0.02). Following this, other studies have produced similar results. For example, Kety and colleagues have performed a number of studies in Denmark. Their most recent results (Kety et al., 1994) come from a national study in which the prevalence of schizophrenia in the biological relatives of probands who had been adopted and subsequently developed schizophrenia was compared with the prevalence in biological relatives of matched control adoptees who did not have schizophrenia. The prevalence of schizophrenia in the adoptive relatives of both proband and control adoptees was also assessed. The prevalence of chronic schizophrenia in the relatives of proband adoptees was 5%, whereas in relatives of control adoptees the prevalence was 0.4% (p = 0.0013). No cases of chronic schizophrenia were found in the adoptive relatives of either proband or control adoptees. Kety and colleagues defined schizophrenia according to their own criteria based on authoritative accounts of the disease and DSM II. Subsequently, Kendler et al. (1994) reanalyzed their data using the DSM III operational definition of schizophrenia. The results remained consistent, with 3.3% of the biological relatives of proband adoptees having a diagnosis of schizophrenia, as opposed to 0.3% of the biological relatives of control adoptees (p < 0.01).
Taken together, although the above results provide compelling evidence for a strong genetic component to schizophrenia, the picture is not completely straightforward. It appears that conditions other than narrowly defined schizophrenia also occur with an unexpectedly high prevalence in the relatives of affected individuals, These are known as schizophrenia spectrum disorders. The best recognized is a collection of personality traits known as schizotypy or schizotypal personality disorder (American Psychiatric Association, 1994) . This occurs in the relatives of probands with schizophrenia more commonly than schizophrenia itself (Kendler et al., 1993b) . Other spectrum disorders include schizoaffective disorder, atypical psychosis, and paranoid personality disorder (Farmer et al., 1987; Kendler et al., 1995) . In their twin study, Farmer et al. (1987) found that when individuals were classified as "affected" if they suffered from various spectrum disorders in addi-149 tion to those with schizophrenia, the difference between MZ and DZ concordance rates increased, consistent with these disorders being genetically related to schizophrenia. Furthermore, in Kendler et al.'s (1994) reanalysis of Kety et al.'s (1994) adoption study data, when the combined prevalence of schizophrenia and spectrum disorders in relatives was assessed, the difference between biological relatives of proband (13%) and control (3%) adoptees was even more significant (p < 0.0001).
A further complication is the observation that in certain families with affected members in multiple generations, individuals may inherit genes from affected parents and have affected offspring but remain well themselves, suggesting that genes relevant to the etiology of schizophrenia may sometimes remain unexpressed. Gottesman and Bertelsen (1989) and Kringlen and Crammer (1989) examined this issue further by studying the offspring of discordant MZ twin pairs. They found that the rates of schizophrenia and related disorders in the offspring of parents with and without schizophrenia did not significantly differ, consistent with the idea that a genotype that predisposes an individual to schizophrenia may be passed on silently between some generations.
Mode of Transmission
How can the above pieces of information be fitted into a model of genetic inheritance for schizophrenia? In the simplest model, the inheritance is accounted for entirely by a single gene with complete penetrance, that is, a gene that always results in the disease in those who carry it. However, this model can be discounted because of the evidence that over half of MZ twins remain well when their twin with the same genes becomes ill. A single gene model with reduced penetrance (Slater and Cowie, 1971 ) is more difficult to evaluate because it can be consistent with a wide range of risks to relatives (James, 1971) . However, when O'Rourke et al. (1982) constrained the genetic parameters of this model within biologically meaningful limits, they found the risks from family and twin study data to be incompatible with the action of a single gene. It also appears unlikely that the entire heritability of schizophrenia could be explained by a collection of different single gene disorders (Risch, 1990) .
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Therefore, models involving multiple genes must be invoked. A useful example is the liabilitythreshold model (Falconer, 1965; Gottesman and Shields, 1967) , in which the genetic contribution to schizophrenia is assumed to comprise multiple genes of small effect, none being necessary or sufficient on their own to cause the disease. The liability to the disease from these multiple genes and unspecified environmental factors is normally distributed in the general population, the disease being expressed when the liability exceeds a certain threshold. This model is compatible with the risks torelatives found in family and twin studies of schizophrenia and may help to explain why schizophrenia has remained relatively common in spite of the low reproductive capacity of sufferers. Spectrum disorders may be incorporated into this model by invoking the concept of multiple thresholds (Reich et al., 1972) . Beyond the first threshold relatively mild forms of the disease, such as schizotypal personality disorder, are expressed. Beyond a second threshold schizophrenia itself is expressed, in this case being seen as a rarer, more severe form of the disease with a higher genetic loading. Studies of subtypes of schizophrenia suggest further thresholds within the clinical syndrome. Farmer et al. (1984) found that MZ twins were not completely concordant when divided according to paranoid and hebephrenic subtypes, suggesting that these subtypes are not the consequence of separate genetic processes. However, concordance rates for schizophrenia of any type were higher when the proband had a hebephrenic, as opposed to a paranoid, presentation. This is compatible with hebephrenic schizophrenia being at the extreme end of the liability curve, occurring less commonly than the paranoid subtype, being a particularly severe form of the disease, and carrying a particularly high genetic loading.
One further possibility is that a gene (or genes) of major effect operates in some families in addition to the polygenic effects that make up the bulk of the genetic liability to schizophrenia as a whole. The plausibility of such a "mixed model" (Morton and MacLean, 1974) has been tested against the simpler polygenic model using segregation analysis (Risch and Baron, 1984; Vogler et al., 1991) . Both models are compatible with data on familial risks, but to date it has not been possible to favor one model over the other.
Finally, we must consider the possibility of genetic heterogeneity in schizophrenia; that is, more than one set of genes predisposing an individual to the same disease. Could genetic heterogeneity explain the wide range of clinical features that come under the umbrella of schizophrenia? Thus far our discussion has assumed a relatively mild form of heterogeneity in which, although a variety of different combinations of genes may predispose an individual to schizophrenia, the individual genes themselves are nonspecific and phenotypic differences are merely the consequence of the size of the genetic loading. However, it remains a possibility that genetic heterogeneity may be reduced by the phenomenon of pleiotropy; that is, one gene resulting in more than one phenotype. Alternatively, it may be increased by some genes exerting more or less specific effects on phenotypic expression. Resolution of this issue awaits the identification of susceptibility genes and the study of their clinical correlates. In the meantime we are left with the problem of how best to define schizophrenia for genetic research, given our current incomplete knowledge. The most usual approach is to employ both a narrow and a broad definition. The narrow definition often comprises schizophrenia and schizoaffective disorder, whereas the broad definition includes these two categories plus other spectrum disorders. The two definitions are analyzed separately and due account is taken of the resultant multiple testing.
Molecular Genetic Studies
Although family, twin, and adoption studies have provided indirect evidence for the genetic mode of transmission of schizophrenia, it has not been possible to proceed any further with these classical approaches, primarily because of statistical limitations. More recent studies using genetic markers offer a much more direct approach to the identification and localization of genes. Genetic markers are reliably measured characters that have a simple mode of transmission and are polymorphic, i.e., there are two or more alleles with a gene frequency of at least 1%. DNA-based markers, whose location is mapped on the human genome, are now available more or less evenly spaced throughout each chromosome, and conse-quently, the entire genome has now become available for investigation.
Strategies for the Detection of Susceptibility Genes
The two main strategies adopted to investigate the relationship between genetic markers and disease are linkage and association studies. Linkage studies using DNA markers require families with multiply affected individuals and are useful in the detection of oligogenic inheritance where a small number of genes have a relatively large effect. In contrast, association studies compare the frequency of marker alleles in a sample of unrelated patients compared with a sample of ethnically matched controls. Association studies are more appropriately employed in the detection of polygenic inheritance, where a large number of genes have relatively minor effects.
Linkage Studies
Linkage occurs when a genetic marker and a disease gene lie close to each other on the same chromosome. In this case, the marker and the disease gene will be found to occur together more often in affected family members than would be expected by chance. This is because linked genes recombine during meiosis less than at the expected rate of 50%, producing a deviation from Mendel's law of independent assortment.
The number of individuals where there has been recombination (recombinants) divided by the total number of offspring gives the recombination fraction, which is, within certain limits, proportional to the distance between the two loci. Recombination fractions can range from close to zero (indicating tight linkage) to 0.5 (indicating independent assortment). In practice, the lod (log of the odds) score method is usually employed to estimate the recombination fraction (0). This is calculated for a range of possible recombination fractions between zero and 0.5. Where the lod score reaches its peak is the maximum likelihood estimate of the recombination fraction, and hence, the distance between the genetic marker and the disease gene. By convention, for simple Mendelian traits, a lod score of 3 or greater (corresponding to an odds on linkage of 1000:1 or greater) is acceptable evidence that linkage is present whereas a lod score of <-2 (100:1 against) excludes linkage (Morton, 1955) .
The two primary aims of linkage analysis are first, to detect linkage between a genetic marker and the disease gene by the demonstration of departure from independent assortment (linkage) and second, to isolate and clone the disease gene itself using a series of molecular techniques. Once the underlying genetic defect or defects have been characterized, it is then possible to examine the structural or metabolic pathology responsible for the disease.
In general, there are two strategies that can be used to detect linkage using DNA markers in complex disorders--the "positional cloning" (or "systematic search") and the "candidate gene" approaches. Positional cloning describes a set of techniques whereby disease genes are identified through their position on the genome rather than through their function. In its initial stages, this approach relies on a systematic search of the genome for linkage, made possible by the availability of systematically constructed linkage maps of the human genome. Once linkage is suggested for a region, other markers are generated that are closer to the disease gene than the existing linked markers (as determined by the lod score). Subsequently, flanking markers can be utilized to proceed in a stepwise fashion toward the disease gene itself.
In contrast, the "candidate gene" approach provides a more targeted alternative to the systematic genome search. This approach targets cloned genes coding proteins that may plausibly be involved in the pathogenesis of the disease.
Linkage Studies in Schizophrenia
Although linkage studies have been successful in identifying disease genes involved in single gene disorders, such as Huntington's disease (Gusella et al., 1983 ) and Friedrich's ataxia (Chamberlain, 1988), they have been less successful when applied to such complex diseases as schizophrenia. There are several reasons that may explain this failure to find linkage in schizophrenia. Linkage studies are based on the assumption that a gene of major effect segregates in at least a proportion of families, that homogeneity exists at least within multiply affected pedigrees, and that the mode of inheritance can at least be approximately inferred. In addition to genetic factors, such as multiple disease susceptibility loci, incomplete penetrance, and epistasis (gene-gene interactions between dif-
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Murphy, Cardno, and McGuffin ferent loci), there are other difficulties that may lead to phenotypic heterogeneity in complex gene disorders. These include varying ages of onset, gene-environment interactions, the presence of nongenetic phenocopies, assortative mating, and diagnostic inconsistencies with a lack of ability to corroborate diagnosis by laboratory investigation. Early linkage studies reported suggestive evidence for linkage between HLA markers and a broadly defined phenotype "schizotaxia" (Turner, 1979) , although subsequent studies were unable to replicate this finding (McGuffin et al., 1983; Goldin et al., 1987) .
The pseudoautosomal region of the X chromosome has been a focus for investigation because schizophrenic siblings are more often of the same sex than of opposite sex (Crow, 1988) . Although Collinge and colleagues (1991) reported that affected sibling pairs shared pseudoautosomal alleles more often than was statistically expected, other studies have failed to find evidence of linkage Wang et al., 1993) .
Cosegregation of such diseases as schizophrenia linked to a chromosomal abnormality may provide important clues for the localization of disease genes. Considerable excitement was generated when Bassett and colleagues (1988) reported an Asian family in Canada where two family members with schizophrenia were each found to have a partial trisomy of chromosome 5 caused by an unbalanced translocation of the long (q) arm of chromosome 5. In the same year, Sherrington and colleagues (1988) reported linkage between schizophrenia and two markers in the 5q11-13 region of their data set of five Icelandic and two British pedigrees. Unfortunately, these results are of doubtful significance because they have not been replicated by other groups (McGuffin et al., 1990) .
Chromosome 11q14-21 was also implicated as a candidate region when linkage was reported between psychiatric illness and a translocation involving chromosome 11 in a large Scottish pedigree (St. Clair, 1990) . Because the dopamine D2 receptor gene also maps to this region, this report generated considerable interest. Unfortunately, replication of these initially promising results has not occurred, either to the D2 receptor (Moises et al., 1991) or in a systematic search of the 11q21-22 region (Gill et al., 1993) .
Velo-cardio-facial syndrome (VCFS), a congenital disorder associated with a microdeletion on chromosome 22q11, has been the focus of some recent interest because patients with VCFS have a higher than expected prevalence of psychosis (Shprintzen et al., 1992) . Further evidence to support chromosome 22qll as a candidate region comes from Karayiorgou and colleagues (1995) , who reported that two of their sample of 100 unrelated schizophrenic patients demonstrated chromosome 22qll deletions.
Chromosome 22q has also been implicated as a possible candidate region following a report by Pulver and colleagues (1994) of the preliminary results of their genome scan. Many, although not atl, studies have reported some evidence to support the hypothesis of linkage in at least a subset of families. A meta-analysis using an analytic method applicable to all studies (an affected sibpair method) demonstrated moderate but not convincing evidence for a minor gene conferring susceptibility to schizophrenia (Schizophrenia Collaborative Linkage Group, 1996) .
There have been several exciting reports suggestive of linkage between schizophrenia and the short arm of chromosome 6. In a study of 186 Irish familieS, Wang and colleagues (1995) reported linkage at the distal end of the short arm of chromosome 6. Straub and colleagues (1995) , in an enlarged sample of 265 families, reported evidence for linkage in approx 30% of families in the 6p22-25 region. Five studies that have attempted to replicate these findings have recently been published. Three have supported the presence of a susceptibility locus on chromosome 6p (Antonarakis et al., 1995; Moises et al., 1995; Schwab et al., 1995) and two reports have been negative (Gurling et al., 1995; Mowry et al., 1995) . Despite these apparently contradictory reports, Lander and Kruglyak (1995) have concluded that these results meet their standard for significant evidence of linkage on chromosome 6p.
A systematic search of the entire genome with sufficient numbers of pedigrees to detect genes operating in only a proportion of pedigrees (genetic heterogeneity) is an expansive undertaking. However, large multicenter collaborative projects are in progress in Europe under the auspices of the European Science Foundation (Leboyer and McGuffin, 1991) and in North America by the National Institute of Mental Health (Cloninger, 1994) . The aim is to use a large sample of multiply affected (multiplex) families and to carry out linkage analysis with evenly spaced markers at about 10 cM intervals. These large collaborative projects will be able to provide sufficient sample size to detect major genetic effects despite the presence of heterogeneity.
In contrast, the candidate gene approach has also been adopted in linkage studies of schizophrenia. Because disturbances in dopamine neurotransmission have been implicated in the pathogenesis of schizophrenia, the genes coding both for dopamine receptors and for the enzymes involved in dopamine metabolism have been considered as targets for the candidate gene strategy. However, Moises and colleagues (1991) found no evidence suggestive of linkage between schizophrenia and the dopamine D2 receptor gene and linkage also seems unlikely with the dopamine D1 (Wildenaur et al., 1991) and D4 receptor genes (Shaikh et al., 1994) .
Concurrently, nonparametric approaches to linkage are being developed that are more appropriately employed in the detection of genes of moderate (rather than major) effect when the mode of transmission is unknown. These studies involve the analysis of pairs of affected relatives, the simplest approach being the affected sibling pair method. Using this method, evidence for linkage is inferred if affected pairs share more alleles at a given marker locus than would be statistically expected. This approach has the advantage that the mode of inheritance need not be specified, and pairs of affected siblings are less atypical than multiplex families. However, the power of the method is low, so large sample sizes are required. This approach has already been used successfully in other complex genetic diseases, such as type I diabetes meUitus (Davies et al., 1994 ) and Alzheimer's disease (Baily-Wilson and Bamba, 1993) . Similar studies involving 200 or more sib pairs affected by schizophrenia are currently underway.
Association Studies
Association studies are easier to perform than linkage studies and require no major assumption other than the existence of a genetic contribution to the disorder. In contrast to linkage analysis, the aim is to compare the frequency of marker alleles in a sample of unrelated patients compared to a sample of ethnically matched controls. Association studies are more appropriately employed in the detection of polygenic inheritance where a large number of genes have relatively minor effects.
A significantly higher frequency of the marker allele in the disease group suggests that the marker itself may have some direct influence on susceptibility to the disease. Alternatively, it suggests that the marker allele may be closely linked to the disease allele. A disadvantage of this approach is that the departure from the expected distribution is only detectable very dose to or at the "associated" mutation. Therefore, because a systematic search through the genome is not yet feasible using this approach, such studies are usually confined either to candidate genes or to those regions that are suggestive of linkage using family-based studies. Other problems include stratification effects, where a section of the population contains a disease and a marker allele more commonly than expected without a causal relationship between them, multiple statistical testing, and pleiotropy, where the same gene may have two or more apparently different effects.
Association Studies in Schizophrenia
Early association studies between schizophrenia and classical markers, such as ABO blood groups and the HLA system, have not shown consistent results and the only replicated finding has been a weak association between schizophrenia and HLA A9 (McGuffin and Sturt, 1986) . More recently, considerable excitement was generated when Lannfelt and colleagues (1992) detected a point mutation in the 5' part of the D3 dopamine receptor gene with the substitution of a serine by a glycine residue in the Bali restriction enzyme site. Subsequently, groups in France and the United Kingdom reported an association between schizophrenia and the homozygous genotype at a two-allele marker D3 receptor locus (Crocq et al., 1992) . A large collaborative study involving 11 centers has succeeded in replicating this association with the strongest findings between highly familial schizophrenia and excess homozygosity at the D3 receptor gene (Williams et al., 1996a) .
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Genes involved in serotonergic neurotransmission have also been examined using the candidate gene approach. Lysergic diethylamide (LSD), which has a similar molecular structure to serotonin, is known to produce psychosis in healthy subjects (Gaddum, 1954) . In addition, Arranz and colleagues (1995) reported an association between a favorable response to Clozapine (which has a high affinity for serotonin receptors) and a polymorphism of the 5-HT2a receptor gene. More recently, Williams and colleagues (1996b) have reported an association between schizophrenia and the 5-HT2a receptor gene in a large European sample.
Other Approaches
Specific gene expression studies using in situ hybridization (ISH) and multiprobe oligonucleotide solution hybridization (MOSH) techniques (O'Donovan et al., 1991) provide further evidence to implicate the D3 receptor gene. These studies have reported that D3 receptor mRNA levels in the brain are increased by both typical and atypical neuroleptics (Buckland et al., 1993) .
Nonspecific gene expression studies, e.g., differential display, may also have a role to play in the identification of specific candidate genes. In this approach, genes are sought that are differentially expressed in the postmortem brains of patients with schizophrenia compared to controls. These genes are then used for genetic marker studies of schizophrenia. Studies involving this technique are currently underway.
A possible clue to the nature of the genetic mutation predisposing to schizophrenia comes from studies of anticipation, the phenomenon whereby a disorder shows decreasing age of onset and/or increasing severity over generations. Recently, expansion of unstable trinucleotide repeat sequences (dynamic mutations) has been demonstrated as a molecular mechanism for anticipation. The underlying cause of Huntington's disease, for example, appears to be the expansion of an unstable trinucleotide repeat on chromosome 4. In addition, a significant negative correlation between repeat length and age of onset has also been reported (Snell et al., 1993) . Recently, O'Donovan and colleagues (1995), using the repeat expansion detection (RED) method to detect the presence (although not the location) of expanded repeats, demonstrated a significant shift toward larger repeats in schizophrenic (and bipolar) probands compared with controls. Other groups have also reported the same phenomena in both schizophrenia and bipolar disorder patients. There are other methods that may be applied to identify and clone such expanded repeats and these studies, involving schizophrenic patients, are currently underway.
Studies using linkage and association methods have assumed that schizophrenia is categorical in nature, i.e., people are either affected or unaffected. Alternatively, it is possible to describe the schizophrenia spectrum in quantitative dimensional terms and assume a continuous phenotype (schizophrenia/schizotypy) with a uniform distribution throughout the population. In this approach, schizotypy scores have been suggested as possible genetic trait markers of vulnerability to schizophrenia. Multiple genes, each with a small effect (quantitative trait loci or QTLs) are assumed to underlie the quantitative and theoretically normally distributed measure of schizophrenia.
Conclusion
There is overwhelming evidence for a significant genetic contribution to the etiology of schizophrenia. Molecular genetic techniques are now sufficiently advanced to be applied to complex genetic disorders with uncertain phenotypes, such as schizophrenia. Large collaborative studies are currently underway that pave the way for the detection of genes of both major and minor effects. We may now be seeing the first consistently replicated results from chromosome 6 and 22 and from candidate genes, such as the dopamine D3 receptor gene. If the presence of even some of these genes is confirmed, it is likely that they will soon be identified.
